Ashland (ASH) Valuation Check After Mixed Share Price Momentum And Reported Earnings Reset

Simply Wall St

Mon, February 16, 2026 at 5:08 PM GMT+9 3 min read

In this article:

ASH

-0.16%

Find your next quality investment with Simply Wall St’s easy and powerful screener, trusted by over 7 million individual investors worldwide.

Why Ashland is on investors’ radar today

Ashland (ASH) has drawn fresh attention after recent share price moves, with the stock showing a negative return over the past month but a positive return over the past 3 months.

For investors, this mixed near term performance, alongside a reported net income loss of US$670.0 million and annual revenue of US$1.8b, raises questions about how the market is currently treating this specialty ingredients business.

See our latest analysis for Ashland.

At a share price of US$60.93, Ashland’s recent 7 day and 30 day share price returns of 2.1% and 3.1% declines contrast with a 90 day share price return of 21.8%. However, the 1 year total shareholder return of 3.3% and 3 year total shareholder return of 37.1% declines indicate that longer term momentum has been fading despite the shorter term rebound.

If Ashland’s mixed track record has you reassessing your watchlist, this could be a good moment to see what else stands out in our screener of 23 top founder-led companies.

With Ashland trading at US$60.93, a reported intrinsic discount of around 50% and a value score of 2, the key question is whether this weakness signals a potential opportunity or if the market already reflects expected future growth.

Most Popular Narrative: 3.6% Undervalued

Against a last close of $60.93, the most followed narrative sees Ashland’s fair value at $63.20, using an 8.56% discount rate to frame future cash flows.

The global shift toward sustainable and bio-based materials, driven by regulatory requirements and consumer preference, continues to gain momentum, benefiting Ashland’s specialty chemicals portfolio that is now more focused on high-value, sustainable, and compliant solutions; this is expected to support top-line revenue growth and margin resilience over the long term.

Read the complete narrative.

Curious what sits behind that fair value? The narrative leans heavily on steadier revenue, improving profit margins, and a reset earnings base that changes how future cash flows stack up.

Result: Fair Value of $63.20 (UNDERVALUED)

Have a read of the narrative in full and understand what’s behind the forecasts.

However, this depends on demand remaining strong in key personal care and life sciences markets, as well as on cost savings continuing once the current efficiency programs run their course.

Find out about the key risks to this Ashland narrative.

Another View: Are The Ratios Sending A Different Message?

While our DCF model indicates Ashland is trading at about a 50% discount to estimated fair value, the current P/S ratio of 1.5x sits in line with the peer average of 1.5x and above the US Chemicals industry at 1.2x. That tight gap suggests less obvious multiple based upside, so which signal do you trust more?

La historia continúa  

See what the numbers say about this price — find out in our valuation breakdown.

NYSE:ASH P/S Ratio as at Feb 2026

Build Your Own Ashland Narrative

If parts of this story do not quite line up with your own view, that is your signal to roll up your sleeves, test the numbers yourself, and shape a version that fits how you see Ashland in just a few minutes, Do it your way.

A great starting point for your Ashland research is our analysis highlighting 2 key rewards and 1 important warning sign that could impact your investment decision.

Looking for more investment ideas?

If Ashland has your attention, do not stop here. Use this momentum to check other opportunities that might suit your goals before they move without you.

Spot potential value opportunities early by scanning companies on our list of 54 high quality undervalued stocks with supportive fundamentals.

Strengthen the quality of your portfolio by focusing on companies highlighted in our solid balance sheet and fundamentals stocks screener (44 results).

Add a punch of income potential by reviewing our 13 dividend fortresses that pair higher yields with resilient profiles.

_ This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned._

Companies discussed in this article include ASH.

Have feedback on this article? Concerned about the content? Get in touch with us directly._ Alternatively, email editorial-team@simplywallst.com_

Condiciones y Política de privacidad

Privacy Dashboard

More Info